Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium.
CALGARY, Oct. 23 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that Dr. Shizuko Sei of SAIC-Frederick, Inc., delivered a poster presentation entitled "In Vivo Efficacy and Replication Dynamics of Intravenously Administered Oncolytic Reovirus in Nude Mice Bearing Human Melanoma Xenografts" at the 20th EORTC-NCI-AACR Symposium...

Advanced Life Sciences Announces Presentations at Fall Scientific and Investor Conferences and Third Quarter 2008 Earnings Conference Call.
CHICAGO, Oct. 21 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. today announced that it has scheduled the following scientific and investor conference presentations and third quarter 2008 earnings conference call. -- 48th Annual ICAAC/IDSA Annual Meeting in Washington D.C. from October 25 through October 28. Advanced Life...

Bioniche Reports Fiscal 2009 First Quarter.
- revenues increase by 37% over same quarter in Fiscal 2008 - (all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON, Nov. 7 /PRNewswire-FirstCall/ -- Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the...

Global warning: reinsurers seek a realistic assessment of a pandemic's potential impact.
[ILLUSTRATION OMITTED] Insurers and reinsurers understandably worry about major natural catastrophes such as the recent Hurricane Ike. Yet hovering in the background, like a ticking bomb, is an even greater concern: a lethal influenza outbreak, which has been haunting the industry since the 2002-2003 outbreak...

A useful, multifunctional cosmetic ingredient.
WHEN AN INGREDIENT performs more than one function in a formula it serves as a very useful tool for the cosmetic chemist. Multifunctional materials help chemical inventory, likely lower the cost, and certainly simplify the formula. An offering called Hest-18-0 from Global Seven, Franklin, NJ makes this claim. Its...

Diagnosis: verruciform xanthoma.
[ILLUSTRATION OMITTED] A 10-year-old boy with severe recessive dystrophic epidermolysis bullosa and malnutrition presented to physicians with a several-year history of an asymptomatic, enlarging verrucous plaque in the left inguinal area. The lesion appeared in the setting of a difficult-to-heal wound. What's your diagnosis? SAN...

First-year HPV vaccination rates 'very good'.
A survey providing the first estimates for human papillomavirus vaccination found that 25% of girls aged 13-17 had received at least one dose of the vaccine, according to a briefing by the Centers for Disease Control and Prevention. "This was very good for a first-year measurement for...

4-hour flu detection test gains FDA approval.
The Food and Drug Administration approved a new test that can diagnose human influenza infections, including the highly pathogenic influenza A (H5N1) virus, and produce results within 4 hours. The device, known as the Human Influenza Virus Real-Time RT-PCR Detection and Characterization Panel (rRT-PCR Flu Panel), was...

First trial of siRNA for a skin disorder offers hope.
KYOTO, JAPAN -- An ongoing, first-in-skin, clinical trial of a small interfering RNA-based therapy for a dermatologic disorder, if successful, will likely accelerate the arrival of a radically new era of tailored therapy for large numbers of patients with other dominant-negative genetic diseases. The phase Ib clinical...